Literature DB >> 15955196

Pregnancy in postural orthostatic tachycardia syndrome.

Kathryn A Glatter1, Dipika Tuteja, Nipavan Chiamvimonvat, Mohamed Hamdan, Jeanny K Park.   

Abstract

INTRODUCTION: Postural orthostatic tachycardia syndrome (POTS) is a rare disease characterized by syncope, sinus tachycardia, and orthostasis due to autonomic dysfunction. METHODS AND
RESULTS: Two women aged 26 and 24 years with severe POTS became pregnant. Both women experienced hyperemesis gravidarum with subsequent marked improvement in their POTS symptoms until 6 months gestation, when their syncope and sinus tachycardia caused clinical decompensation. Both patients delivered healthy babies at 37 weeks by elective cesarean section.
CONCLUSION: In long-term follow-up, both women reported improvement in their prepartum symptoms. We describe the first report, to our knowledge, of two successful pregnancy outcomes in severe POTS, including the first report of midodrine use in pregnant women.

Entities:  

Mesh:

Year:  2005        PMID: 15955196     DOI: 10.1111/j.1540-8159.2005.50026.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  Postural orthostatic tachycardia syndrome and general anesthesia: a series of 13 cases.

Authors:  Jennifer A Rabbitts; Cornelius B Groenewald; Adam K Jacob; Phillip A Low; Timothy B Curry
Journal:  J Clin Anesth       Date:  2011-08       Impact factor: 9.452

2.  Postural orthostatic tachycardia syndrome complicating pregnancy: a case report with review of literature.

Authors:  N Pramya; Shyjus Puliyathinkal; Haritha Sagili; D Jayalaksmi; P Reddi Rani
Journal:  Obstet Med       Date:  2012-03-29

3.  A Case Report and Review of Postural Orthostatic Tachycardia Syndrome in Pregnancy.

Authors:  Brianna Lide; Sina Haeri
Journal:  AJP Rep       Date:  2015-03-04

4.  Postpartum postural orthostatic tachycardia syndrome in a patient with the joint hypermobility syndrome.

Authors:  Khalil Kanjwal; Beverly Karabin; Yousuf Kanjwal; Blair P Grubb
Journal:  Cardiol Res Pract       Date:  2009-10-11       Impact factor: 1.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.